A Safety and Efficacy Study of Tralokinumab in Adults With Asthma
Public ClinicalTrials.gov record NCT01402986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Uncontrolled, Severe Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether the addition of tralokinumab to standard asthma medication is effective in the treatment of adults with asthma.
Study identification
- NCT ID
- NCT01402986
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 689 participants
Conditions and interventions
Conditions
Interventions
- Placebo Q2W Other
- Tralokinumab 300 mg, Q2W Biological
- Placebo, Q2/4W Other
- Tralokinumab 300 mg, Q2/4W Biological
Other · Biological
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2011 (Type not available)
- Primary completion
- Jun 2013 (Actual)
- Completion
- Feb 2014 (Actual)
- Last update posted
- Apr 4, 2017
2011 – 2014
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Rancho Mirage | California | — | — |
| Research Site | Centennial | Colorado | — | — |
| Research Site | New Haven | Connecticut | — | — |
| Research Site | Cocoa | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Winter Park | Florida | — | — |
| Research Site | Albany | Georgia | — | — |
| Research Site | Fargo | North Dakota | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Upland | Pennsylvania | — | — |
| Research Site | Killeen | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01402986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2017 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01402986 live on ClinicalTrials.gov.